Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 2051 results found since Jan 2013.
Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients - Lessons learned from the COVID-19 pandemic
Biomed Pharmacother. 2023 Aug 3;165:115254. doi: 10.1016/j.biopha.2023.115254. Online ahead of print.ABSTRACTDespite the development of new biological and synthetic targeted therapies, methotrexate remains one of the most commonly used immunomodulatory drugs in rheumatology. However, its effect on the immunogenicity of vaccines has been studied only to a limited extent until recently, resulting in the lack of clear guidelines on the use of methotrexate during vaccination. Significant progress was made during the COVID-19 pandemic due to the dynamic development of research on vaccines, including patients with autoimmune inf...
Source: Herpes - August 5, 2023 Category: Infectious Diseases Authors: Jakub Wro ński Marzena Ciechomska Ewa Kuca-Warnawin Source Type: research
The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 years
CONCLUSION: Modestly higher RZV coverage in US adults 50-59 years could reduce the clinical burden associated with HZ and may result in societal cost savings. These findings demonstrate the potential value of increasing RZV vaccination in this population.PMID:37541822 | DOI:10.1016/j.vaccine.2023.07.025
Source: Herpes - August 4, 2023 Category: Infectious Diseases Authors: David Singer Ahmed Salem Nikita Stempniewicz Siyu Ma Sara Poston Desmond Curran Source Type: research
Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study
CONCLUSIONS: Our study showed that SARS-CoV2 infection is associated with an increased risk of HZ in patients with IBD.PMID:37540900 | DOI:10.1093/ibd/izad162
Source: Herpes - August 4, 2023 Category: Infectious Diseases Authors: Aakash Desai Aakriti Soni Mary S Hayney Jana G Hashash Gursimran S Kochhar Francis A Farraye Freddy Caldera Source Type: research
Herpes zoster infection following SARS-CoV-2 vaccine BNT162b2
Ital J Dermatol Venerol. 2023 Aug;158(4):364-365. doi: 10.23736/S2784-8671.23.07466-2.NO ABSTRACTPMID:37539506 | DOI:10.23736/S2784-8671.23.07466-2
Source: Herpes - August 4, 2023 Category: Infectious Diseases Authors: Wanda Lauro Francesco Cillo Francesca Nastro Gabriella Fabbrocini Claudio Marasca Source Type: research
The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 years
CONCLUSION: Modestly higher RZV coverage in US adults 50-59 years could reduce the clinical burden associated with HZ and may result in societal cost savings. These findings demonstrate the potential value of increasing RZV vaccination in this population.PMID:37541822 | DOI:10.1016/j.vaccine.2023.07.025
Source: Vaccine - August 4, 2023 Category: Allergy & Immunology Authors: David Singer Ahmed Salem Nikita Stempniewicz Siyu Ma Sara Poston Desmond Curran Source Type: research
Herpes zoster infection following SARS-CoV-2 vaccine BNT162b2
Ital J Dermatol Venerol. 2023 Aug;158(4):364-365. doi: 10.23736/S2784-8671.23.07466-2.NO ABSTRACTPMID:37539506 | DOI:10.23736/S2784-8671.23.07466-2
Source: Herpes - August 4, 2023 Category: Infectious Diseases Authors: Wanda Lauro Francesco Cillo Francesca Nastro Gabriella Fabbrocini Claudio Marasca Source Type: research
The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50-59 years
CONCLUSION: Modestly higher RZV coverage in US adults 50-59 years could reduce the clinical burden associated with HZ and may result in societal cost savings. These findings demonstrate the potential value of increasing RZV vaccination in this population.PMID:37541822 | DOI:10.1016/j.vaccine.2023.07.025
Source: Herpes - August 4, 2023 Category: Infectious Diseases Authors: David Singer Ahmed Salem Nikita Stempniewicz Siyu Ma Sara Poston Desmond Curran Source Type: research
Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study
CONCLUSIONS: Our study showed that SARS-CoV2 infection is associated with an increased risk of HZ in patients with IBD.PMID:37540900 | DOI:10.1093/ibd/izad162
Source: Herpes - August 4, 2023 Category: Infectious Diseases Authors: Aakash Desai Aakriti Soni Mary S Hayney Jana G Hashash Gursimran S Kochhar Francis A Farraye Freddy Caldera Source Type: research
Herpes zoster infection following SARS-CoV-2 vaccine BNT162b2
Ital J Dermatol Venerol. 2023 Aug;158(4):364-365. doi: 10.23736/S2784-8671.23.07466-2.NO ABSTRACTPMID:37539506 | DOI:10.23736/S2784-8671.23.07466-2
Source: Herpes - August 4, 2023 Category: Infectious Diseases Authors: Wanda Lauro Francesco Cillo Francesca Nastro Gabriella Fabbrocini Claudio Marasca Source Type: research
Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel
Blood Cancer J. 2023 Aug 1;13(1):116. doi: 10.1038/s41408-023-00879-7.ABSTRACTBispecific antibodies (BsAbs) are emerging as an important novel class of immunotherapeutic agents for the treatment of multiple myeloma (MM), and are set to be more widely used in clinical practice. However, this new class of therapies is associated with a distinct adverse event (AE) profile that includes cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, as well as AEs leading to increased infection risk such as cytopenias and hypogammaglobulinemia, and infections themselves. As preliminary data with this clas...
Source: Herpes - August 1, 2023 Category: Infectious Diseases Authors: Noopur Raje Kenneth Anderson Hermann Einsele Yvonne Efebera Francesca Gay Sarah P Hammond Alexander M Lesokhin Sagar Lonial Heinz Ludwig Philippe Moreau Krina Patel Karthik Ramasamy Maria-Victoria Mateos Source Type: research
Infections, Vaccinations, and Risk of Alzheimer's Disease (AD)/Dementia: Probable Involvement of Reactivated Herpes Simplex Virus Type 1
Adv Exp Med Biol. 2023;1423:279-280. doi: 10.1007/978-3-031-31978-5_28.ABSTRACTInfections are associated with cognitive decline and increased risk of AD/dementia (Sochocka M, Zwolinska K, Leszek J. Curr Neuropharmacol 15:996-1009, 2017; Ou YN, Zhu JX, Hou XH, Shen XN, Xu W, Dong Q, et al. J Alzheimers Dis 75:299-309, 2020; Sipilä PN, Heikkilä N, Lindbohm JV, Hakulinen C, Vahtera J, Elovainio M, et al. Lancet Infect Dis 21:1557-1567, 2021; Damiano RF, Guedes BF, de Rocca CC, de Padua Serafim A, Castro LHM, Munhoz CD, et al. Eur Arch Psychiatry Clin Neurosci 272:139-154, 2022), and some studies have shown that vaccinations...
Source: Herpes - July 31, 2023 Category: Infectious Diseases Authors: Ruth F Itzhaki Source Type: research
Addressing racial inequality and its effects on vaccination rate: A trial comparing a pharmacist and peer educational program (MOTIVATE) in diverse older adults
CONCLUSIONS: Both interventions significantly improved knowledge and trust toward vaccination and retained their effect 1 month after the program. The 2 effective community-based education models should be expanded to ensure timely and trusted information is available to educate older adults about vaccine-preventable diseases. Further research is encouraged to assess the long-term cost-effectiveness of these models' utilization on a larger scale. DISCLOSURES: Dr Schafer is an employee of Merck; however, at the time of the project, he was a professor at Thomas Jefferson University. The other authors have no conflicts of int...
Source: Herpes - July 31, 2023 Category: Infectious Diseases Authors: Katherine M Prioli Ayse Akincigil Tarlan Namvar Jocelyn Mitchell-Williams Jason J Schafer Renee C Cunningham Lynn Fields-Harris Megan McCoy Ronald Vertsman Ashley Guesnier Laura T Pizzi Source Type: research
Herpes Zoster Virus: Should Patients With Chronic Respiratory Diseases Be Vaccinated?
Arch Bronconeumol. 2023 Jul 14:S0300-2896(23)00227-2. doi: 10.1016/j.arbres.2023.07.012. Online ahead of print.NO ABSTRACTPMID:37517934 | DOI:10.1016/j.arbres.2023.07.012
Source: Herpes - July 30, 2023 Category: Infectious Diseases Authors: Rosario Men éndez Paula Gonz ález-Jiménez Ra úl Méndez Source Type: research
